4-17511987-C-T
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong
The NM_000320.3(QDPR):c.68G>A(p.Gly23Asp) variant causes a missense change. The variant allele was found at a frequency of 0.0000211 in 1,610,618 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G23A) has been classified as Uncertain significance.
Frequency
Consequence
NM_000320.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
QDPR | NM_000320.3 | c.68G>A | p.Gly23Asp | missense_variant | Exon 1 of 7 | ENST00000281243.10 | NP_000311.2 | |
QDPR | NM_001306140.2 | c.68G>A | p.Gly23Asp | missense_variant | Exon 1 of 6 | NP_001293069.1 | ||
QDPR | NR_156494.2 | n.104G>A | non_coding_transcript_exon_variant | Exon 1 of 6 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152004Hom.: 0 Cov.: 31
GnomAD4 exome AF: 0.0000219 AC: 32AN: 1458614Hom.: 0 Cov.: 32 AF XY: 0.0000193 AC XY: 14AN XY: 725662
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152004Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74258
ClinVar
Submissions by phenotype
Dihydropteridine reductase deficiency Pathogenic:4
Variant summary: QDPR c.68G>A (p.Gly23Asp) results in a non-conservative amino acid change to a highly conserved residue (HGMD) in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 236940 control chromosomes (gnomAD). c.68G>A has been reported in the literature in multiple homozygous individuals affected with Dihydropteridine Reductase Deficiency (Dianzani_1998, Farrigua_2007), and at least one compound heterozygous individual with another pathogenic variant. These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function, finding a severe reduction in enzymatic activity in vitro (Zhang_1996). The following publications have been ascertained in the context of this evaluation (PMID: 9744478, 17188538). One submitter has cited a clinical-significance assessment for this variant to ClinVar after 2014 and classified it as likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
- -
- -
This sequence change replaces glycine, which is neutral and non-polar, with aspartic acid, which is acidic and polar, at codon 23 of the QDPR protein (p.Gly23Asp). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with biopterin-deficient hyperphenylalaninemia (PMID: 8326489, 8518287, 27246466). ClinVar contains an entry for this variant (Variation ID: 490). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects QDPR function (PMID: 8518287). For these reasons, this variant has been classified as Pathogenic. -
Hyperphenylalaninemia due to tetrahydrobiopterin deficiency Pathogenic:1
proband,female, 1 month old, preliminary screening 358umol/L, erythrocytic dihydroteredine reductase determination 0.84nmol/ (min.5mmdisc) decreased, 40 days confirmed DHPRD -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at